View all veterinary jobs
VetSurgeon.org publishes a curated feed of veterinary news for practising veterinary surgeons, with a primary focus on the UK profession.
We select stories based on their practical relevance, clinical interest, or professional significance — filtering out noise so busy vets can stay informed quickly.
Our coverage includes:
We report across all areas of practice, including companion animal, farm, equine and exotic species.
Our editorial approach is deliberately selective and concise. We prioritise clarity and relevance over volume, aiming to make each story worth your time.
You can follow VetSurgeon News by subscribing to the daily, weekly or monthly email digest, or via our channels on Facebook and LinkedIn.
Complete Veterinary Care (CVC) is to launch the BooBooLoon, a new alternative to the Elizabethan collar at BSAVA Congress.
According to the company, the inflatable collar offers comfort and protection advantages over old style Elizabethan collars and other devices that restrict pets from harming surgical wounds and irritating skin disorders.
The BooBooLoon, which is made in the US by a manufacturer called Headroom, will be distributed by CVC to veterinary professionals and pet shops. The collar will be available in five sizes from extra small through to extra large.
Marcy Colangelo, President of Headroom invented the device when her boxer dog Mitzi had surgery for skin cancer. She said: "I just couldn't stand leaving that cone on her. It was like putting her head in a tunnel."
Inspired by her own travel pillow, she came up with the BooBooLoon.
Marcy added: "I know the entire CVC Group administrative and veterinarian management team are enthusiastic about their upcoming BooBooLoon inflatable pet recovery collar launch. The CVC Group is very experienced and is committed to providing excellent service and quality to the veterinary profession and to independent pet shops throughout the United Kingdom."
Novartis Animal Health has announced that it has assumed marketing responsibilities for the joint health supplement Cosequin in the United Kingdom and Ireland.
Cosequin, which contains glucosamine and chondroitin sulfate, is available in a range of presentations for dogs, cats, and horses.
The product, which was previously marketed by MSD, is the leading joint health supplement among veterinary surgeons in the US and Europe.
Novartis says Cosequin is an important addition to its Orthopaedic Health Category, which in 2009 introduced Onsior (robenacoxib), the first tissue-selective pain relief for cats and dogs.
Gaynor Hillier, General Manager UK & Ireland Novartis Animal Health said: "Our strategic intent is to expand our presence in orthopaedic health to address prevention, diagnosis, and treatment in a more comprehensive manner. Cosequin represents an important step toward achieving this objective".
Cosequin is available from Novartis Animal Health in the United Kingdom and Ireland, from licensed veterinary wholesalers. For more information on Cosequin, contact your Novartis Animal Health Territory Manager.
The Petplan/Panasonic Monitoring Kit, which was launched last year, allows pet owners and veterinary staff to check on their animals via an app on their smartphone or tablet.
Petplan says is it being used by some veterinary practices to help provide additional security and monitoring capability within the practice.
The kit includes an indoor camera, which comes with an in-built temperature sensor and night vision, a door sensor and Smart Plug which can be remotely activated to turn on a radio, lamp, portable heater or fan to help keep animals content.
The kit also contains an SD card which allows clients to save and share video footage of their pet in its home environment with their veterinary surgeon, and practices to record and share footage with their staff or clients.
Isabella Von Mesterhazy, Head of Marketing at Petplan, said "For Petplan, keeping pets healthy always has been and always will be our priority. We worry about our pets when we are not with them and the pet Monitoring Kit addresses this problem by providing welcome reassurance that they are safe and well. We are delighted to be able to share this exclusive, time limited offer with our customers and veterinary partners to allow them to check in on their pets, from wherever they are."
To find out more and access a discount code, veterinary staff should login to petplanvet.co.uk.
Sophia Salmon MRCVS from Central CPD said: "All of the major corporate chains in the UK now deliver a significant proportion of their clinical and non-clinical staff training via online learning platforms. These systems form an important part of professional development, training standardisation and even performance evaluation.
"However, learning platforms can be expensive to procure and develop, as well as being time-consuming to maintain, and therefore may not be viable for smaller businesses."
Central CPD has used its experience providing online learning to several of the UK’s major corporate veterinary groups to create 'Central CPD On-Demand', which features over 1500 clinical and non-clinical CPD videos for vets, nurses, managers and receptionists.
There's a new practice subscription package which, developed with whole-team learning in mind, costs £2000 per year for up to twenty people (veterinary surgeons, nurses or management staff).
Central CPD says the new package allows individuals and practices to set their own learning plan for the year, and for mentors to build and supervise training programmes for other staff members.
Practices can add their own content, such as policy documents, in order to assist with the delivery of compulsory elements of staff training.
Central CPD says its service is a fraction of the cost of procuring and populating an off-the-shelf learning platform, and the company is staffed by vets and vet nurses who are available to provide one-to-one advice and support to help practices set up their team’s platform and get the most out of the system.
For more information, visit: https://centralcpd.co.uk/
Linda, who was first elected to Council in 2019, will take up the post at the RCVS Annual General Meeting in July.
She is currently Chair of both the RCVS Standards Committee and the Riding Establishment Subcommittee and also sits on the Primary Qualifications Subcommittee and the Preliminary Investigation and Disciplinary Liaison Committee.
Outside of the RCVS, Linda is a Director at The George Veterinary Group in Wiltshire, an independently owned practice providing equine, farm, pig and small animal veterinary services.
Linda has been part of The George since 1992, having started her career in practice in Winchester after graduating from Bristol University Vet School the previous year.
She is a member of the British Veterinary Association, the British Equine Veterinary Association and the Society of Practising Veterinary Surgeons and is also a Trustee for Brooke – an international equine animal welfare charity.
Linda said: “Having recently been re-elected to Council for another term by fellow members of our profession, I am really looking forward to joining the Officer Team in my role as Junior Vice-President and I thank my colleagues on Council for their endorsement and support.
“Since joining Council four years ago, I have learned a lot – one of the difficulties I have observed is the tension of our profession having a Royal College which regulates.
"Wearing two hats is never easy, and being both our leadership body and our regulator can position the College in a difficult place in the eyes of its members.
"There are, however, advantages for us as a profession in being self-regulating.
“As Junior Vice-President, I look forward to increasing Council’s direct contact with vets working in first-opinion practice.
"Working as part of a large independently owned practice, I am aware of many of the day-to-day issues currently facing the different species sectors.
"I understand what it takes to be a good workplace delivering veterinary care in a commercial environment and want, through my contribution to Council and the governance and regulation of our profession, to support others to have a successful and fulfilling career in practice.”
Photo: Linda (right) shaking hands with current President Melissa Donald MRCVS
A donation of 200 Tracer microchips by Bayer is helping to save one of the world's largest and rarest species of frog against extinction. A deadly fungal disease, responsible for decimating global amphibian populations, is threatening the last known wild population of the 'mountain chicken' frog (Leptodactylus fallax).
The eastern Caribbean island of Montserrat is the last global stronghold for this species - known locally as mountain chicken due to its taste. As recently as 2002, chytridomycosis wiped out the majority of mountain chicken frogs on the island of Dominica. Recent tests on dead frogs found in the west of Montserrat have confirmed the presence of this disease.
The Durrell Wildlife Conservation Trust has been working in Montserrat since the early 1990s to support the local government in the protection of the island's vast biodiversity. The mountain chicken has been an important species, and Durrell holds the largest safety net population at its Jersey headquarters.
In response to the positive identification of the disease, Durrell has launched an emergency plan to rescue healthy frogs and put in place longer treatment and management plans for the protection of the species.
Bayer's donation of 200 Tracer microchips will be used to individually identify the captive mountain chickens held by Durrell to help manage a breeding programme. Durrell is also testing the feasibility of treating the frogs with antifungals in their natural habitat, and the use of the donation of microchips will be essential to allow individual frogs to be monitored to assess the outcomes of treatment regimes.
Durrell's head of veterinary services, Javier López, has worked with mountain chickens for a number of years, and explains that the disease could very quickly wipe out the species. Captive populations of healthy frogs, such as the one in Jersey, could be used to initiate re-introductions back to the wild or in disease-free areas.
Following a nationwide search to find the UK's top veterinary professionals for 2010, Petplan has announced the winners of the Veterinary Awards.
The Petplan Veterinary Awards recognise and applaud staff and practices throughout the country that have delivered an exceptional level of care to the nation's pets and their owners.
Alison Andrew, Petplan's Marketing Manager, says she is thrilled by the ongoing success of the awards. "Britain is known to be an animal-loving nation and with millions of households owning cats and dogs, pets play a central part in family life. The Petplan Veterinary Awards give us the opportunity, on behalf of all pet owners across the UK, to thank the veterinary profession for the outstanding service they provide to our pets.
"This is the 11th year of the awards and we received over 1800 nominations, which really highlights the high regard that the profession and pet owners have for these awards."
VET OF THE YEARMike Hewitt, Wendover Heights Veterinary Centre, Buckinghamshire Having worked in the profession for over 20 years Mike is highly respected by clients, valued by colleagues and loved by pets. Having received so many heartfelt customer nominations, Mike's constant professionalism and approachable manner shone through.
VET NURSE OF THE YEARLouise Want, Feldon Veterinary Centre, WarwickshireThe constant support and care Louise provides to both her colleagues and clients really stood out. She is a great inspiration to all and having worked in the veterinary profession for 30 years, Louise is as passionate and dedicated, as when she first started.
VET RECEPTIONIST OF THE YEAR Carol Dawson, Kingsteignton Veterinary Group, Devon Carol's compassionate and professional manner really impressed all the judges. Clients instantly feel at ease because of her caring smile and welcoming attitude, while her colleagues find her a great inspiration.
VET PRACTICE OF THE YEAR Mill House Veterinary Surgery and Hospital, Norfolk Mill House Veterinary Surgery and Hospital provides an incredibly high level of service to their clients, and as a collective are extremely dedicated and welcoming. Taking pride in their work they are known by their clients for being efficient, friendly and helpful.
The Veterinary Development Council (VDC) is conducting a survey to investigate the role of paraprofessionals and technicians in veterinary practice, and is asking vets in large animal, equine, and mixed practices to complete a short survey.
The VDC says that information from the survey will help inform discussions on the regulation of technicians.
The survey will take between 5 and 10 minutes to complete and can be found on the BVA website at www.bva.co.uk/vdc. The BVA has also emailed the survey directly to practices.
The survey has been devised by the VDC working group looking at the role of the veterinary-led team, chaired by BVA Past President Professor Bill Reilly. This is one of three working groups that will report to the VDC:
Professor Reilly said: "The relationship between veterinary surgeons and technicians is vital but it varies from practice to practice.
"The working group on the role of the veterinary-led team aims to take a snapshot of how services, such as artificial insemination and foot trimming, are currently delivered, and gauge how veterinary surgeons feel about other services being delivered by non-veterinarians in the future.
"I hope veterinary surgeons in large, mixed and equine practice will take 10 minutes to complete our survey to help us map the current use of technicians in veterinary practice and help shape our future discussions."
Virbac has launched the BackHome Mini Chip, a microchip which is 8mm long compared to the existing standard which is 12mm.
The new Mini Chips are made of a pharmaceutical grade glass with an anti-migration coating. Because of their smaller size, they can be implanted with a needle that is 34% smaller than the standard needle. Virbac says this can minimise stress and discomfort during implantation.
Virbac has also announced a partnership with VetEnvoy, a service which works with practice management software to enable pet and owner registration details for BackHome Mini Chips to be uploaded to the Petlog database at the press of a button, saving support staff time completing online or paper application forms and reducing the number of errors.
Sarah Walker MRCVS, Product Manager, said: "Microchipping is the most effective way for owners to protect their pets and will soon become compulsory for dogs in England and Wales. Some owners are deterred from undertaking this important and simple procedure because they are concerned that it may be painful. Because our new BackHome Mini Chips are smaller and are implanted with a smaller needle, we hope that practices will be able to reassure their clients that microchipping will not cause their pet discomfort - and that the protection it offers will last a lifetime.
“Our relationship with VetEnvoy will also spare enabled practices some of the administration time spent processing microchip details, and reduce the number of mistakes in registration and any resulting complaints.
"Client information on BackHome Mini Chips is stored on Petlog, the UK's largest pet database, giving owners the best possible chance of being reunited with their pet, as long as they keep their registration details up to date."
PBD Biotech says the Actiphage test offers the potential to revolutionise control of bovine TB by allowing detection of the disease within hours from a blood or milk sample.
Last November, the Welsh Government announced a new policy that allowed the use of non-validated tests such as Actiphage in herds affected by a TB breakdown. It followed a similar protocol to one authorised by the UK Government last year for cattle herds in England after the test was used as part of a successful private eradication plan on a Devon dairy farm.
Mossman Farming, in Ceredigion, is located in an area of chronic breakdown. It is a spring-calving milking herd with a total stock of 529, to date 312 dairy cows have been slaughtered. Farmer Chris Mossman agreed to trial Actiphage after hearing about the Gatcombe pilot.
Chris said: "TB is a massive problem in Ceredigion, so when I heard about Actiphage’s use at Gatacombe, helping to clear that dairy herd for the first time in six years, I wanted to try and replicate those findings here. Me – and many other farmers – are losing large numbers of animals. I’m trying to do all I can to get rid of this disease from my herd."
In Spring 2019, The Office of the Chief Veterinary Officer for Wales granted permission for Robert Price-Jones MRCVS to use Actiphage to screen high-risk cattle for M. bovis.
Robert, who has been leading the trial, said: "Actiphage is able to identify the presence of relatively low numbers of M. bovis in the blood stream of infected cattle. It is not dependent upon an immune system response to the pathogen - in contrast to current validated tests - and so has greater sensitivity than such as the official Tuberculin SICCT skin test.
"The benefit of using Actiphage is that it offers the potential for eradicating the disease from the farm; as early identification of animals at risk of bovine TB enables heightened disease management and control."
Under the terms of the Welsh Government’s protocol, cattle not condemned for slaughter can be tested with Actiphage. Those that give a positive result are identified with a ‘management’ marker, monitored and milked separately.
To prevent further contamination of the environment and to minimise risk to uninfected cattle, animals found to be ‘shedders’ are removed from the farm.
Although a decision to remove cattle based on a non-validated test will be at the farmers’ own expense, the APHA (Animal and Plant Health Agency) has confirmed that during the trial, where a positive result is confirmed with statutory tests, the animals will be removed with compensation as normal.
So far, 100 animals from Mossman Farming have been tested with Actiphage and Robert Price-Jones is preparing a paper to publish the findings in early 2020.
PBD Biotech is now seeking more farms to trial Actiphage in order to gain the World Organisation for Animal Health (OIE) validation. The company is offering reduced cost testing to support trials where the findings are made available to support validation of the test.
The new service will offer all the chemo and surgical options.
Matthew (pictured right) said: "At Eastcott, we have amazing facilities and staff to care for pets with cancer, so we are proud to launch this comprehensive new oncology service.
"We have a custom-designed chemotherapy room, multiple sterile theatres - including our interventional radiology theatre - and state-of-the-art imaging facilities, with a 64-slice CT scanner and advanced ultrasound equipment.
"We are able to manage the full range of tumour types including maxillofacial tumours, from diagnosis to treatment.
"We use a variety of techniques to allow accurate staging, including minimally invasive biopsy and lymph node harvesting, as well as sentinel lymph node mapping and advanced medical imaging.
"Treatment options include advanced soft tissue surgical oncology and the full range of medical oncology. This may involve standard and metronomic chemotherapy, intracavitary chemotherapy and immunotherapy, such as the melanoma vaccine.
"We pride ourselves on helping owners understand our treatment plan through the whole process and emphasise the importance of making the right decisions to maintain the welfare of our patients.”
For more information, visit www.eastcottreferrals.co.uk.
'Period prevalence and mortality rates associated with hypocholesterolaemia in dogs and cats: 1,375 cases1' determined the period prevalence of hypocholesterolaemia and the associated mortality rates in dogs and cats at the Veterinary Medical Teaching Hospital, University of California, Davis.
The medical records of cats and dogs presenting to the hospital from 1st September 2011 to 30th August 2016 were retrospectively reviewed to identify all animals that had at least 1 cholesterol measurement; a total of 16,977 dogs and 3,788 cats were identified. Patient signalment and clinical information were collated from the medical records, including the primary disease processes in patients with moderate to severe hypocholesterolaemia. The period prevalence and mortality rate of hypocholesterolaemia were calculated.
The period prevalence of hypocholesterolaemia was 7.0% in dogs and 4.7% in cats. The mortality rate of hypocholesteraemic dogs and cats was 12% in both species, which was significantly higher than that of animals with normal serum cholesterol.
Steven Epstein, corresponding author for the paper, said: 'The odds of death in dogs and cats with hypocholesterolaemia were 3.2 and 2.5 times higher than in those with normocholesterolaemia respectively. Furthermore, there was a significant linear trend towards higher mortality in association with more severe hypocholesterolaemia in both species.
'Disease of the hepatic, gastrointestinal and lymphoreticular systems were most commonly associated with hypocholesterolaemia, and infectious and neoplastic disease were the most commonly associated pathophysiological processes in both species. In dogs with neoplasia, lymphoma was over-represented.'
Nicola Di Girolamo, Editor of JSAP said: 'These findings suggest that low cholesterol levels are associated with mortality in canine and feline patients. It is not clear whether hypocholesterolaemia is simply a marker for disease severity, or if it has active physiological effects contributing to poor outcomes. At this stage, it seems indicated to enhance intensity of diagnostic effort and therapy for affected animals.'
The full article can be found in the November issue of the Journal of Small Animal Practice which is free for BSAVA members. It can also be read online here: https://www.onlinelibrary.wiley.com/doi/10.1111/jsap.13204
Reference
Voting for this year’s election will take place from 15th March until 5pm on Friday 23 April 2021 and the 14 candidates are:
This year, four candidates will be elected to serve a four-year term.
For the first time, the RCVS Council election will be carried out completely online.
Eleanor Ferguson, RCVS Registrar and Returning Officer for the election, said: “Due to the coronavirus pandemic and the issues that it has caused regarding disruption to the postal service, the RCVS has gained permission from the Privy Council to temporarily amend our Election Scheme, a document that governs how we run our elections, to allow voting to take place entirely online this year. This means that physical ballot papers will not be distributed to veterinary surgeons eligible to vote this year.
“The small number of veterinary surgeons for whom we do not hold an email address will receive a letter with instructions on how to vote online, in addition to their security code to allow them access to their unique voting website. If they need further help there will also be the opportunity for them to call Civica Election Services, which runs the election on our behalf, who will assist them with casting their vote.”
Ahead of the start of the election, the RCVS is also inviting members of the profession to submit one question each for the candidates. The candidates will then be asked to record a short video of themselves answering two of the questions of their choice which will be published when the election starts.
Questions can be submitted by emailing vetvote21@rcvs.org.uk or via the RCVS Twitter account (@theRCVS) using the hashtag #vetvote21.
The full candidate biographies and manifestoes have already been published on the RCVS website and are available to view at: www.rcvs.org.uk/vetvote21
Members of the profession have until Wednesday 24 February 2021 to submit their question.
BSAVA’s client information leaflets are designed to be used as part of the veterinary consultation and provide information to help owners understand what is involved in a procedure or examination, including the reasons for it, the preparation required, any associated risks and what happens during and after the procedure.
They are available in a PDF format which can be printed and stamped with the veterinary practice details or emailed to clients.
Elise Robertson, ABVS American Board-Certified Diplomate Feline Practice and author of the endoscopic Client Information Leaflets, said: ‘The client information leaflets were created due to the need for accurate and reliable information from reputable sources."
BSAVA’s Head of Publishing, Ian Mellor, said: "This new factsheet brings our total number of client leaflets to 178. Our client leaflets have been downloaded more than 10,000 times in the past year and are an important part of our drive to improve the health and welfare of small animals by providing practical resources to the veterinary profession.’
The new leaflet is available via the BSAVA Library (https://www.bsavalibrary.com/content/cilgroupprocedures).
Access to the entire range of client information leaflets (including canine and feline behaviour, exotic pets and medicines) is available for an annual subscription of £40; BSAVA members have access to these leaflets as one of their membership benefits.
BSAVA welcomes suggestions for new topics to cover in its client information leaflets.
Send your ideas to publications@bsava.com.
Omniflora paste is designed to provide fast acting support in acute digestive upset or strategically ahead of perceived stressful events such as travel or veterinary appointments.
It contains probiotics, prebiotics, adsorbents, parabiotics, postbiotics, electrolytes and nutrients.
Omniflora tablets are available for animals who resist an oral syringe.
The tablets contain probiotics, prebiotics and adsorbent clay and fibre.
Veterinary nurse and sales manager, Tara Evans, said: “Digestive upset in cats and dogs is common.
"We wanted to provide vets and pet owners with an easy-to-use solution that can be used in practice or at home.
"One tube of paste lasts for three consecutive days to support cats and dogs as they recover from gastrointestinal upset.”
"As well as supporting the gut in acute episodes of digestive upset such as diarrhoea, Omniflora can be used ahead of time in stressful events such as travelling, visiting the groomers, or any planned veterinary procedures such as surgeries or blood tests.”
Omniflora can be ordered here https://www.vitaanimalhealth.com/product/omniflora
The review will consider whether the UK Veterinary Medicines Regulations 2013, which were were originally derived from EU legislation, protect animal and public health without adding unnecessary regulatory burden.
Anyone is able to share their views and experiences of the regulations, but the VMD is especially interested in hearing from vets, vet nurses, SQPs, marketing authorisation holders, farmers and pet owners.
Responses must be submitted before 23:59 on 26th September 2025
https://consult.defra.gov.uk/vmd-policy-development-and-delivery-office/mmd-act-2021-stakeholder-survey
Following a survey which indicates that veterinary surgeons are largely using unproven supplements to manage early-stage osteoarthritis, Hill's Pet Nutrition is calling upon vets to use evidence-based clinical nutrition to manage the condition.
The survey, which was carried out by independent market research firm Zyman Group, found that vets are more likely to give supplements than any other treatment in early stage osteoarthritis: 66% of cases receive supplements, 45% are given NSAIDs, and only 20% receive dietetic pet food.2
According to Hill's, its Prescription Diet j/d dry is clinically proven to improve mobility in osteoarthritic dogs in as little as 21 days; and 28 days in cats.3,4 Furthermore, the clinical study assigned to j/d is classified as Grade 1 level evidence - the highest grade reflecting the validity of clinical evidence. Another study has shown that Prescription Diet j/d also helps reduce NSAID dosage by up to 25 percent in dogs.5 This quality of evidence is, says Hill's, in contrast to many supplements.
John Innes, Professor of Small Animal Surgery at Liverpool, was involved in some of the early work on j/d: "Our results showed that the EPA in Hill's Prescription Diet j/d Canine pet food helped to reduce proteoglycan loss from cartilage. This would have beneficial effects in helping to preserve loss of cartilage. By preserving the cartilage, we can reduce pain in the long-term and ensure greater mobility for dogs with osteoarthritis."
Hill's has also announced that because a substantial majority of vets and nurses said that they felt that natural GACs have a positive effect in osteoarthritis1, its Prescription Diet j/d dry has been enriched with glucosamine and chondroitin sulphate.
Hill's j/d programme is now backed with money off vouchers, to improve client acceptance of veterinary recommendation. Clients who register on the website http://www.hillspetmobility.co.uk/,or http://www.hillspetmobility.ie/, will receive two £10 (or €10) money off e-coupons to use in clinic on their next purchases of j/d. They will also receive monthly e-mails containing information on how to take care of their pet with mobility problems, and help drive them back into the clinic for check-ups.
Veterinary surgeons who would like more information on the studies proving clinical efficacy, or score cards and trial guides for clients, should contact their Hill's Territory manager or call 0800 242438 or in ROI 1 800 626002. Clients can also fill in the scorecard online at www.hillspetmobility.co.uk or http://www.hillspetmobility.ie/
References
Boehringer Ingelheim Vetmedica has announced that it will be launching Bovela, a new viral diarrhoea (BVD) vaccine, to farmers during April 2015.
Allan Henderson from Boehringer said: "BVD remains the most common viral disease affecting cattle throughout Europe, despite vaccines being available for over 15 years. We asked farmers why this was the case and, without exception, they remarked that current vaccine protocols are unwieldy, requiring precise timings making them hard to follow.
"Bovela is a unique one-shot vaccine that can be used in cattle from three months of age and also whether pregnant or not. Other, currently available vaccines require a two-dose primary course with boosters annually or even every six months thereafter."
BVD is spread within herds and to new herds through the presence of persistently infected (PI) animals. PIs can look relatively healthy and show no outward signs of infection but, as they were exposed to the virus as a foetus, have become virus carriers. If they are born alive, they will shed virus consistently throughout their lives so perpetuating the cycle of infection.
Alan said: "The foetal control delivered by Bovela gives absolute confidence that cows will not produce PIs. This, alongside the drastically improved convenience will undoubtedly make Bovela the natural choice for many farmers, both on beef and dairy farms."
According to Boehringer, around 60% of cattle in the EU test positive for exposure to the BVD virus and, although BVD type 1 is currently the most common form, outbreaks of BVD type 2, were confirmed in 2013 and 2014 in Belgium, Germany and The Netherlands. BVD type 2 is generally a more serious disease, with high levels of mortality and while the virus has been identified in UK, it has not yet been identified as the cause of serious outbreaks of disease in cattle.
Alan said: "Bovela is the first and only vaccine in UK which has been proven to protect cattle from BVD type 1 and 2. It has been in development for 17 years and, gained a marketing authorisation following assessment of an unprecedented quantity of data generated in both beef and dairy herds.
"Work has looked at the efficacy of Bovela in preventing the production of PI calves and against type 1 and 2 BVD as well as confirming its efficacy in young calves as young as three months of age as their natural maternal protection wears off. Trials also confirmed vaccine safety generally and during various stages of pregnancy. We do not believe that any other BVD vaccine has been tested as rigorously."
Zoetis has launched PetDialog and HorseDialog, the only treatment reminder apps for pet and horse owners which veterinary practices can customise with their own branding.
The app is downloadable from the Apple and Android app stores, but is only accessible by inputting a unique practice identity code.
Once the app is unlocked, owners can then input details of any medications their pet is taking and the date its healthcheck / vaccinations are due, after which they'll receive a practice-branded email reminder.
It's a similar idea to Bayer's reminder app released earlier this year, but with the very clever addition of practice branding.
John Toole, Product Manager at Zoetis said: "This is absolutely the right time to launch this app. Smartphone ownership has rapidly increased from 38% to 60% in the last three years and by 2015 it is predicted that 73% of the UK population will own a Smartphone. The use of Smartphones is no longer just the domain of the young - use and ownership is pretty evenly spread among age groups between 24 and 64, with greatest growth among the 44 -74 age group over the past three years. It comes as no surprise that recent market research confirms 57% of UK pet owners own an Android or iOS device.
"Health businesses are the most trusted by UK mobile users when it comes to receiving mobile messages. More than 11 million consumers have opted in to receive mobile messages from health companies, particularly to take advantage of appointment reminders. This form of communication can really boost loyalty where vet practices are concerned, as 74% of users say that mobile messages that had a use or benefit would maintain or enhance their loyalty to that brand.
"PetDialog has been a significant investment for us and with the help of our customers we plan to re-invest in a robust development stream to ensure the app becomes a valuable tool for pet owners and practices alike. To help practices launch and market the app we've developed an extensive bespoke range of marketing support materials from web pages and email templates to practice posters that come alive in the waiting room with augmented reality."
VetSurgeon gave the app a very quick trial. We found registration simple and easy. Clear navigation. Very good first impression.
Except ...
Honestly, whose idea was it that even the most pathologically insane pet owner would possibly, even once in a million years, want to record (and chart) the amount of time they spend hugging their pet. And not just that, but also to categorise their pet-hugging activities according to whether it was 'Morning Cuddles', 'Afternoon Hugs' or 'Evening Snuggles'. Someone at Zoetis' digital agency must have been smoking something very strong when they came up with that one.
Similarly, the ability to record the amount of time spent playing with the dog, breaking it down into specific activities such as: 'Fetch', Tug of War', 'General Playing', is surely targeted at the 0.0000000001% of the pet owning population that really should be getting some sort of professional help.
That said, the overall idea and execution is top notch. Provided Zoetis removes the madder elements of the app at the next upgrade, it'll get 5 stars out of 5. Meantime, it's still highly recommended.
For more information about the app, contact your Zoetis Account Manager
The study, which examined cattle farmers’ and veterinary surgeons' opinions of pain-induced distress associated with disbudding, analgesia and attitudes and the use of non-steroidal anti-inflammatory drugs (NSAIDs), suggests that in particular, vets need to refine their understanding of farmers’ priorities, and how they guide clients on methods to improve calf welfare.
There have been a number of studies into the pain-induced distress resulting from the disbudding procedure. All methods of disbudding (apart from chemical cauterisation) in the UK require the use of a corneal nerve local anaesthetic blockade but there are currently no legislative requirements for the use of NSAIDs for disbudding – it is at the discretion of the farmer or veterinary surgeon carrying out the procedure. NSAIDs are routinely used in companion animals and equine practice, but less so in farm animals.
This new study, conducted by researchers at the Royal Veterinary College (RVC) in Hertfordshire and Aran Vet Clinic in Gwynedd, looked at the attitudes of farmers and vets on pain perception and pain management methods for disbudding. A total of 118 vets and 140 farmers contributed to the study. Of the respondents:
The study concluded that veterinary surgeons underestimate the influences of welfare and analgesic duration and effectiveness on farmers' decisions, and overrated cost impact. This perception could have a negative effect on veterinary recommendation.
The authors of the study therefore advise that steps should be taken to address the current inadequacies in the communications between vets and clients in conveying the practicalities and potential benefits of using NSAIDs.
Dr Troy Gibson, PhD, PGDipSci, BSc, Lecturer in Animal Welfare Science at the Royal Veterinary College said: "Despite the large amount of evidence of the benefits of NSAIDs for disbudding, it is disappointing that their use is still not widespread. This may partly be due to the only recent licencing of one NSAID for cattle. However, from our work it is clear that one of the key barriers to wider uptake is the breakdown in communication between veterinarians and their clients in conveying the cost, practicalities and potential benefits of NSAID use for disbudding. The wider use of NSAIDs in combination with local anaesthetics during disbudding would significantly improve calf welfare."
The practice's first residents are Sara Cermeno Fernandez and Lucy Venman (pictured right), who began their programmes last month after completing successful internships.
Cave’s clinical director Nele Van den Steen, an RCVS and European specialist in internal medicine, said: “We are naturally very pleased to have achieved this milestone and are delighted to get started, with our first residents Sara and Lucy continuing their career development with us.
“To be approved for a residency programme, you have to show you can support the caseload required and provide the training which the residents will need.
“So, this accreditation shows we have the integrity and the capacity to support the programme, which is a notable achievement and a ringing endorsement of our work here at Cave.”
For more information, visit cave-vet-specialists.co.uk.
Humanimal Trust is the only organisation in the UK with the sole purpose of progressing One Medicine, driving collaboration between vets, doctors, nurses and researchers so advances in both human and animal medicine can be achieved faster.
The seminar, entitled One Medicine in Action – Awareness, Collaboration and Change, follows on from the Trust’s inaugural symposium last year when a roadmap was created on how to develop closer links between human and veterinary medical and research professionals.
This year’s event will look at ways to put the roadmap into action through awareness raising, increased collaboration and change.
Professor Roberto La Ragione, Chair of Trustees at Humanimal Trust (pictured right), said “We know that when animal and human health professionals and scientists come together, great things happen.
"Last year’s symposium, which was part of our ‘Stronger Together’ campaign, was a huge success.
"It drew an audience from across the UK and Europe, as well as Chile, the United States, Singapore and Australia.
“Not only did it provide a real opportunity to explore ways to achieve more ethical and fair medical progress for all, but it also allowed connections to be made and relationships to be forged that wouldn’t otherwise exist.”
Miss Anna Radford, a Consultant in Paediatric Surgery at Hull University NHS Trust and Leeds Children’s Hospital, who is speaking at the seminar in May, said: “I was introduced to a diagnostics company working in the animal medical care field at last year’s symposium and through them, we have set up a new collaboration with the aim of determining whether this sort of diagnostic technology developed with companion animal medicine in mind, could potentially also be useful to help diagnose urinary, joint and cerebrospinal fluid infections in a busy NHS hospital setting.”
Other speakers at this year’s event include Dr Deborah Thomson, Founder and President of One Health Lessons, an organisation that inspires children and adults around the world to value the interconnection between human health and the health of the environment, plants and animals.
Dr Simon Doherty, a Senior Lecturer at the Institute of Global Food Security at Queen’s University in Belfast will highlight organisations that are successfully working together to improve the sustainability of dairy, meat and fish production to feed a growing global population, as well as the opportunities that exist for collaboration within the agri-food sector.
Dr Doug Brown, CEO of the British Society for Immunology, will share some of the most notable examples of joined-up approaches in human and animal health research from across the Society’s membership, with a particular focus on veterinary immunology.
The seminar, which will run from 2pm until 5.15pm BST, will end with a panel Q&A session, chaired by Humanimal Trust Trustee and Consultant Respiratory Physician at the University Hospital Southampton NHS Foundation Trust, Dr Ben Marshall.
Attendance is free and registration is now open to all human and veterinary medical professionals and students, and the allied health and scientific disciplines.
To find out more and register, visit www.humanimaltrust.org.uk
However, the attainment of clinical remission did reduce the likelihood of subsequent death due to gastrointestinal disease.
In the study titled “Outcome of chronic inflammatory enteropathy in cats: 65 cases (2011-2021)”1, cats diagnosed with chronic inflammatory enteropathy were retrospectively identified from three medical records databases, and follow-up information obtained from the referring veterinary surgeon.
This information was used to determine if clinicopathological variables were associated with death due to gastrointestinal disease in diagnosed cats.
Sixty-five cats with chronic inflammatory enteropathy were included in the study, with follow-up information available for 54 cats (83%).
Of these, 37% (n=20) were euthanised due to gastrointestinal disease and 46% (n=25) were alive and in clinical remission, with 64% (n=16) of these diagnosed with food-responsive enteropathy.
The study did not find a correlation between the tested clinicopathological variables, measured at the time of histopathological diagnosis, and death due to gastrointestinal disease, or length of survival in these cats before death due to gastrointestinal disease.
This, the authors say, suggests that alternative diagnostic measures should be identified to definitively investigate outcome and survival in cats with chronic inflammatory enteropathy.
The study also adds weight to previous research which recommends the use of therapeutic diets in cats with chronic inflammatory enteropathy, although further research is needed to clarify a favourable treatment protocol.
First author, Dr Yuvani Bandara, said: “Knowledge that the attainment of clinical remission reduces the likelihood of subsequent death due to feline chronic inflammatory enteropathy is important for veterinary surgeons and owners.
"We hope that our findings can act as a foundation for further research to investigate factors that support the attainment of clinical remission in affected cats.
"Thank you to BSAVA PetSavers for funding this study.”
The talk, which is sponsored by Supreme Petfoods, will be co-delivered by Craig Tessyman, who works alongside Molly as Exotics Veterinary Nurse Team Leader at Rutland House Veterinary Referrals.
The presentation will focus on the main aspects of emergency care, including best practice for managing these cases in first opinion practice.
Topics will include restoring and maintaining fluid balance, cardio-pulmonary resuscitation (CPR), analgesia options and the importance of appropriate monitoring.
Molly said: “The basic principles of emergency care apply to all species, but with small herbivores, rapid intervention is crucial as their delicate physiology can quickly spiral into crisis when they become unwell.
"In this session, Craig and I will share practical tips that vets and nurses can implement immediately, without requiring specialist equipment, to help manage these challenging cases.”
The sixty minute talk will start at 12.50pm in the Gallery Suite 3-4.
For those unable to attend the live event, a recorded version of the presentation will be available here: https://supremepetfoods.com/vet-zone/cpd-webinars-and-videos/
The RCVS has announced that the Code of Professional Conduct has been updated to restrict - from April 2016 - the use of the word specialist and its derivatives in veterinary practice marketing and promotional materials, except when referring to an RCVS Recognised Specialist.
Alternatives for practitioners who want to describe a special area of expertise in their marketing materials, but who are not on the RCVS list of Specialists include: 'Special interest in ...', 'Experienced in ...', 'Advanced qualifications in ...', or, for those who hold the status, 'Advanced Practitioner'.
The College says the changes will also apply to European Veterinary Specialists fully recognised by the European Board of Veterinary Specialisation, who will now need to join the RCVS list if they wish to use the title in the UK. However, European Specialists will be offered a simplified application process and a 50% reduction in the fee, because their revalidation is carried out by their specialist European college.
The College has also extended the deadline for new applications for Specialist Status to 30th September 2015. The deadline for re-applications by existing RCVS Specialists remains 14th August 2015.
In addition to changing the Code, the College has also amended Chapter 23 of its supporting guidance ('Advertising and publicity') to give more detailed advice on use of the terms 'specialist' and 'specialising in' in the context of advertising and referrals.
Gordon Hockey, RCVS Registrar, said: "Specialist status is not easy to achieve. Those who hold it have achieved a postgraduate qualification at a minimum of Diploma level and have satisfied us that they make an active contribution in their speciality, for example, through publishing academic papers.
"The change to the Code of Professional Conduct is therefore intended to ensure the integrity of the specialist list and title, so that those who do not have RCVS-recognised qualifications, experience and expertise do not claim or imply they hold such a status.
"These changes will benefit the public and, ultimately, animal welfare by clearly identifying those who have specialised knowledge and skills. They should also aid members of the broader profession in the UK when they are deciding who they should refer cases to.
"We recognise this represents a significant change which is why we have allowed a 'bedding in' period before the change comes into force, as well as extending the deadline for applications."
To find out more about applying for Specialist status, visit www.rcvs.org.uk/specialists. The List of RCVS Specialists is available at www.rcvs.org.uk/listofspecialists. Details of the updates made to the Code can be found at www.rcvs.org.uk/vetcode. These changes have also been reflected in the RCVS Code of Professional Conduct app which can be downloaded from www.rcvs.org.uk/codeapp.